Ian Gillies Sr. avoids looking at the photos he captured during his son’s hospital stay at the Health Sciences Centre in St. John’s. Recalling the challenging period is enough for him as he focuses on moving forward. “We’ve been through a lot, and it has given me a different outlook,” he shared.
The ordeal began in the summer of 2023 when Ian Gillies Jr., fresh out of the College of North Atlantic, felt unusually fatigued for a 22-year-old. His energy levels plummeted to the extent that he struggled to climb stairs at their Conception Bay South home, leading to a wheelchair trip to the doctor.
Beside facing constipation and bloating, Gillies Jr. found solace in their hot tub to alleviate the discomfort. However, a turning point arrived in October when the family doctor urgently advised a trip to the emergency room due to concerning test results. By then, Gillies Jr. had gained nearly 60 pounds due to fluid retention.
Medical professionals embarked on a diagnostic journey ruling out common illnesses but faced a puzzling case. Gallons of accumulated fluid were drained, and amidst the chaos, Gillies Sr. assisted his son through the challenging times.
Dr. Steven Rowe, a first-year internal medicine resident, played a critical role in identifying the rare TAFRO syndrome afflicting Gillies Jr. After hours of research and a Eureka moment one night, Rowe’s findings aligned perfectly with the symptoms, sparking a positive turn in the diagnosis and treatment plan.
The rarity of Castleman and TAFRO diseases posed challenges, with Gillies Jr. becoming the first recognized case in Newfoundland and Labrador. The subsequent treatment involving siltuximab stabilized Gillies Jr., allowing him to return home for Christmas and resume a semblance of normalcy with regular medical follow-ups.
Following this medical breakthrough, Rowe collaborated with experts to publish a case report shedding light on diagnosing Castleman and TAFRO diseases promptly. Their research unveiled a novel approach using a simple blood test to differentiate between TAFRO and HLH diseases efficiently, potentially saving lives by expediting diagnosis and treatment.
The impact of their study, published in prestigious medical journals, underscores the importance of swift diagnosis in treating rare diseases. The collaboration between medical institutions signals a significant stride in rare disease research, offering hope to patients worldwide.
Through perseverance and dedication, Rowe and his team have paved the way for improved diagnostic methods and treatment strategies in the realm of rare diseases. Gillies Jr. and his family acknowledge the transformative efforts that led to his recovery, emphasizing the profound impact on their lives.